Show simple item record

dc.contributor.authorMercader Ruiz, Jon
dc.contributor.authorBeitia, Maider
dc.contributor.authorDelgado, Diego
dc.contributor.authorSánchez, Pello
dc.contributor.authorGuadilla, Jorge
dc.contributor.authorPérez de Arrilucea, Cristina
dc.contributor.authorBenito López, Fernando ORCID
dc.contributor.authorBasabe Desmonts, Lourdes ORCID
dc.contributor.authorSánchez, Mikel
dc.date.accessioned2023-10-02T17:06:30Z
dc.date.available2023-10-02T17:06:30Z
dc.date.issued2023-09-13
dc.identifier.citationJournal of Clinical Medicine 12(18) : (2023) // Article ID 5941es_ES
dc.identifier.issn2077-0383
dc.identifier.urihttp://hdl.handle.net/10810/62727
dc.description.abstractPlatelet-Rich Plasma (PRP) is an autologous biological product which, due to its regenerative capacity, is currently used in different fields of medicine. This biological treatment has proven to be effective in numerous research studies due to its high content of growth factors released by platelets. However, the current systems used to obtain PRP do not enrich the growth factors and cytokines outside platelets. Considering this, the present work aims to develop a new technique by which all the biomolecules present in plasma are enriched. Thus, a new method based on ultrafiltration has been developed for the obtaining of the novel PRP. By this method, ultrafiltration of the plasma water is carried out using a 3KDa filtering unit. The results showed that the technique was able to concentrate extraplatelet factors, such as IGF-1 and HGF, in contrast with conventional plasmas. Thus, the cultured cells responded with increased viability to this new PRP. These results could provide a new approach to the treatment of injuries requiring regenerative medicine, potentially improving the outcomes of the conventional PRPs.es_ES
dc.description.sponsorshipThis research was funded by “Ministerio de Ciencia y Educación de España” under the grant PID2020-120313GB-I00/AIE/10.13039/501100011033, FEDER “una manera de hacer Europa”, and Gobierno Vasco Dpto. de Educación for the consolidation of the research groups (IT1633-22). Important to mention the founding support given to J. Mercader Ruiz by the UPV/EHU PIF Industrial “Ayudas para la formación de personal investigador en colaboración con instituciones y empresas” (reference PIFIND19/03) and to M. Beitia for the Torres Quevedo program grant (reference PTQ- 3122019-010386) of the Spanish Ministerio de Economía y Competitividad.es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectplatelet-rich plasmaes_ES
dc.subjecthydrogeles_ES
dc.subjectwater filtrationes_ES
dc.subjectplateletses_ES
dc.subjectbiomoleculeses_ES
dc.subjectgrowth factorses_ES
dc.titleMethod Based on Ultrafiltration to Obtain a Plasma Rich in Platelet and Plasma Growth Factorses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.date.updated2023-09-27T12:36:26Z
dc.rights.holder© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).es_ES
dc.relation.publisherversionhttps://www.mdpi.com/2077-0383/12/18/5941es_ES
dc.identifier.doi10.3390/jcm12185941
dc.departamentoesQuímica analítica
dc.departamentoesZoología y biología celular animal
dc.departamentoeuKimika analitikoa
dc.departamentoeuZoologia eta animalia zelulen biologia


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Except where otherwise noted, this item's license is described as © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).